{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:42:23Z","timestamp":1793983343717,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart &amp; Vasculature"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijcha.2022.100989","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T12:59:22Z","timestamp":1646225962000},"page":"100989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)"],"prefix":"10.1016","volume":"39","author":[{"given":"\u00d6zer","family":"Badak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R\u0131za","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugay","family":"\u00d6nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylan","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Can","family":"Yontar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"\u015eat\u0131ro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertu\u011frul","family":"Okuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Melek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim Etem","family":"Dural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcha.2022.100989_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.16","article-title":"Atrial fibrillation","volume":"2","author":"Lip","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"5","key":"10.1016\/j.ijcha.2022.100989_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcha.2022.100989_b0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"2 Suppl","key":"10.1016\/j.ijcha.2022.100989_b0020","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijcha.2022.100989_b0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15420\/aer.2017.50.1","article-title":"The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation","volume":"7","author":"Vranckx","year":"2018","journal-title":"Arrhythm. Electrophysiol. Rev."},{"issue":"9","key":"10.1016\/j.ijcha.2022.100989_b0030","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCRESAHA.116.306925","article-title":"Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants","volume":"118","author":"Chan","year":"2016","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcha.2022.100989_b0035","doi-asserted-by":"crossref","first-page":"e031341","DOI":"10.1136\/bmjopen-2019-031341","article-title":"Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK","volume":"9","author":"Garc\u00eda Rodr\u00edguez","year":"2019","journal-title":"BMJ Open."},{"issue":"11","key":"10.1016\/j.ijcha.2022.100989_b0040","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.amjmed.2016.05.041","article-title":"Evaluation of dose-reduced direct oral anticoagulant therapy","volume":"129","author":"Barra","year":"2016","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.ijcha.2022.100989_b0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/imj.13118","article-title":"New oral anticoagulants: appropriateness of prescribing in real-world setting","volume":"46","author":"Pattullo","year":"2016","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijcha.2022.100989_b0050","doi-asserted-by":"crossref","unstructured":"O. Basaran, V. Dogan, O. Beton, M. Tekinalp, A.C. Aykan, E. Kalaycioglu, I. Bolat, O. Tasar, \u00d6. Safak, M. Kalcik, M. Yaman, S. Inci, B. Altintas, S. Kalkan, C. Kirma, M. Biteker, Collaborators, Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study, Medicine (Baltimore). 95 (35) (2016 Aug) e4672.","DOI":"10.1097\/MD.0000000000004672"},{"issue":"3","key":"10.1016\/j.ijcha.2022.100989_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1076029617693940","article-title":"Drug Adherence in Patients with Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR","volume":"24","author":"Emren","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"223","key":"10.1016\/j.ijcha.2022.100989_b0060","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijcard.2016.08.303","article-title":"Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire","volume":"15","author":"Desteghe","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2022.100989_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pec.2020.07.008","article-title":"Sociodemographic, behavioral, and clinical factors associated with low atrial fibrillation knowledge among older adults with atrial fibrillation: The SAGE-AF study","volume":"104","author":"Sedney","year":"2021","journal-title":"Patient Educ. Couns."},{"issue":"2","key":"10.1016\/j.ijcha.2022.100989_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hrtlng.2007.02.006","article-title":"Knowledge and self-management behaviors of patients with recently detected atrial fibrillation","volume":"37","author":"McCabe","year":"2008","journal-title":"Heart Lung."},{"issue":"6","key":"10.1016\/j.ijcha.2022.100989_b0075","doi-asserted-by":"crossref","first-page":"e12304","DOI":"10.1111\/1755-5922.12304","article-title":"The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation","volume":"35","author":"Rolls","year":"2017","journal-title":"Cardiovasc. Ther."},{"issue":"12","key":"10.1016\/j.ijcha.2022.100989_b0080","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/europace\/euv233","volume":"17","author":"Lane","year":"2015","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ijcha.2022.100989_b0085","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.19102\/icrm.2020.110802","article-title":"Engaging Patients in Atrial Fibrillation Management via Digital Health Technology: The Impact of Tailored Messaging","volume":"11","author":"Toscos","year":"2020","journal-title":"J. Innov. Card. Rhythm. Manag."},{"issue":"3","key":"10.1016\/j.ijcha.2022.100989_b0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1474515118804353","article-title":"Effect of reinforced, targeted in-person education using the Jessa Atrial fibrillation Knowledge Questionnaire in patients with atrial fibrillation: A randomized controlled trial","volume":"18","author":"Desteghe","year":"2019","journal-title":"Eur. J. Cardiovasc. Nurs."},{"issue":"7","key":"10.1016\/j.ijcha.2022.100989_b0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/MBC.0000000000000349","article-title":"A new gap in the novel anticoagulants' era: undertreatment","volume":"26","author":"Belen","year":"2015","journal-title":"Blood Coagul Fibrinolysis."},{"issue":"4","key":"10.1016\/j.ijcha.2022.100989_b0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1076029615614395","article-title":"PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)","volume":"23","author":"Basaran","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"10","key":"10.1016\/j.ijcha.2022.100989_b0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2459\/JCM.0000000000001043","article-title":"INSIgHT (Italian NOACs San Raffaele Hospital) registry investigators. Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation","volume":"21","author":"Godino","year":"2020","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"12","key":"10.1016\/j.ijcha.2022.100989_b0110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"GARFIELD-AF Investigators. ion Receiving Nonrecommended Doses of Direct Oral Anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2022.100989_b0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007633","volume":"7","author":"Steinberg","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.ijcha.2022.100989_b0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.acvd.2017.04.008","article-title":"Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients","volume":"111","author":"Dillinger","year":"2018","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"21","key":"10.1016\/j.ijcha.2022.100989_b0125","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2019-01-846048","article-title":"How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism","volume":"133","author":"Chan","year":"2019","journal-title":"Blood"}],"container-title":["IJC Heart &amp; Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:10:39Z","timestamp":1762492239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906722000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":25,"alternative-id":["S2352906722000380"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.100989","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.100989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Pfizer PFE. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100989"}}